Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Alx Oncology Holdings Inc (ALXO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,820,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   ALX Oncology Holdings is a holding company. Through its subsidiaries, Co. is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on capabilities in protein engineering and oncology led by the CD47 blocker, evorpacept. Co.'s primary product candidate, evorpacept, is a CD47 blocking biologic in development as a combination therapy with other anti-cancer agents for treatment of various oncology indications, including myelodysplastic syndromes, acute myeloid leukemia, head and neck squamous cell carcinoma, gastric/gastroesophageal junction and breast cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,400 4,400 4,400 4,400
Total Buy Value $49,771 $49,771 $49,771 $49,771
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 102,000 118,548 132,059 138,283
Total Sell Value $1,442,904 $1,687,879 $1,781,027 $1,849,929
Total People Sold 2 4 4 4
Total Sell Transactions 4 9 14 18
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 101
  Page 4 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Pons Jaume President & CEO   •       •      –    2021-01-26 4 OE $0.99 $9,900 D/D 10,000 551,346     -
   Graham G. Walmsley Director   –       •      –    2020-12-14 4 B $76.00 $1,520,000 I/I 20,000 995,000 2.1     -
   Plain Henry A Jr 10% Owner   –       –       •   2020-07-21 4 A $0.00 $0 I/I 3,691,171 120,212     -
   Plain Henry A Jr 10% Owner   –       –       •   2020-07-21 4 B $19.00 $7,600,000 I/I 400,000 22,000 1.5     -
   Lettmann Jason Director   –       •       •   2020-07-21 4 A $0.00 $0 I/I 3,691,171 120,212     -
   Lettmann Jason Director   –       •       •   2020-07-21 4 B $19.00 $7,600,000 I/I 400,000 22,000 2.25     -
   Lettmann Jason Director   –       •       •   2020-07-21 4 A $0.00 $0 D/D 88,704 107,220     -
   Venbio Global Strategic Gp Ii, Ltd. See Remarks   •       •       •   2020-07-21 4 B $19.00 $57,000 D/D 3,000 99,406 0.01     -
   Venbio Global Strategic Gp Ii, Ltd. See Remarks   •       •       •   2020-07-21 4 B $19.00 $16,150,000 I/I 850,000 5,268,325 0.01     -
   Venbio Global Strategic Gp Ii, Ltd. See Remarks   •       •       •   2020-07-21 4 A $0.00 $0 I/I 7,041,969 4,418,325     -
   Venbio Global Strategic Gp Ii, Ltd. See Remarks   •       •       •   2020-07-21 4 A $0.00 $0 D/D 78,175 96,406     -
   Vivo Opportunity Fund, L.p. 10% Owner   –       –       •   2020-07-21 4 B $19.00 $18,525,000 I/I 975,000 185,526 1.5     -
   Vivo Opportunity Fund, L.p. 10% Owner   –       –       •   2020-07-21 4 A $0.00 $0 I/I 3,245,048 4,034,522     -
   Hemrajani Rekha Director   –       •      –    2020-07-21 4 B $19.00 $57,000 D/D 3,000 3,000 2.39     -
   Pietzke Steffen VP Fin & Chief Acct Officer   •       –      –    2020-07-21 4 B $19.00 $57,000 D/D 3,000 3,000 2.74     -
   Graham G. Walmsley Director   –       •      –    2020-07-21 4 B $19.00 $18,525,000 I/I 975,000 975,000 2.1     -
   Graham G. Walmsley Director   –       •      –    2020-07-21 4 A $0.00 $0 I/I 2,105,901 2,161,981     -
   Goodman Corey S Executive Chairman   –       •       •   2020-07-21 4 A $0.00 $0 I/I 7,188,585 54,083     -
   Goodman Corey S Executive Chairman   –       •       •   2020-07-21 4 B $19.00 $16,150,000 I/I 850,000 850,000 2.25     -
   Garcia Peter S Chief Financial Officer   •       –      –    2020-07-21 4 B $19.00 $57,000 D/D 3,000 3,000 2.74     -
   Pons Jaume President and CEO   •       •      –    2020-07-21 4 A $0.00 $0 D/D 27,292 541,346     -
   Caffo Nathan Chief Business Officer   •       –      –    2020-07-21 4 A $0.00 $0 I/I 10,529 11,254     -
   Venbio Global Strategic Gp Ii, Ltd.   –       –       •   2020-07-16 3 IO $0.00 $0 I/I 0 461,962     -
   Pons Jaume President and CEOOfficer   •       •      –    2020-07-16 3 IO $0.00 $0 D/D 0 509,072     -
   Goodman Corey S Director   –       •       •   2020-07-16 3 IO $0.00 $0 I/I 0 461,962     -

  101 Records found
  1  2  3  4  5   
  Page 4 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed